Published in J Consult Clin Psychol on June 01, 1999
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26
Efficacy of brief strategic family therapy in modifying Hispanic adolescent behavior problems and substance use. J Fam Psychol (2003) 2.65
The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol (2006) 2.31
A meta-analysis of interventions to reduce loneliness. Pers Soc Psychol Rev (2010) 1.88
Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Qual Life Res (2006) 1.68
Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia. Pain (2014) 1.50
Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors. Clin Gastroenterol Hepatol (2011) 1.48
Commentary on the multimodal treatment study of children with ADHD. J Abnorm Child Psychol (2000) 1.47
Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial. Explore (NY) (2011) 1.44
Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: a randomized trial. J Child Psychol Psychiatry (2012) 1.41
Computer-assisted management of attention-deficit/hyperactivity disorder. Pediatrics (2011) 1.40
Determination of the clinical importance of study results. J Gen Intern Med (2002) 1.34
Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med (2008) 1.31
Treatment response, symptom remission, and wellness in obsessive-compulsive disorder. J Clin Psychiatry (2013) 1.28
Predicting longitudinal patterns of functional deficits in children with traumatic brain injury. Neuropsychology (2009) 1.19
A randomized trial of MBSR versus aerobic exercise for social anxiety disorder. J Clin Psychol (2012) 1.17
Short-term neuropsychological recovery in clients with substance use disorders. Alcohol Clin Exp Res (2005) 1.15
Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend (2014) 1.10
Parenting intervention for externalizing behavior problems in children born premature: an initial examination. J Dev Behav Pediatr (2010) 1.10
A randomized controlled pilot study of a brief web-based mindfulness training. BMC Psychiatry (2011) 1.06
The video assessment of simulated encounters-revised (VASE-R): reliability and validity of a revised measure of motivational interviewing skills. Drug Alcohol Depend (2008) 1.06
Clinical significance and predictors of treatment response to cognitive-behavior therapy for insomnia secondary to chronic pain. J Behav Med (2002) 1.06
Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: which differences are clinically important? Health Qual Life Outcomes (2012) 1.01
A modified QuickDASH-9 provides a valid outcome instrument for upper limb function. BMC Musculoskelet Disord (2009) 1.01
Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT). Health Qual Life Outcomes (2013) 1.00
Few girls with childhood attention-deficit/hyperactivity disorder show positive adjustment during adolescence. J Clin Child Adolesc Psychol (2009) 0.99
Problem-solving treatment and coping styles in primary care for minor depression. J Consult Clin Psychol (2008) 0.97
A Community Mental Health Implementation of Parent-Child Interaction Therapy (PCIT). J Child Fam Stud (2010) 0.95
Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention. J Consult Clin Psychol (2011) 0.94
Family therapy for adolescents with poorly controlled diabetes: initial test of clinical significance. J Pediatr Psychol (2009) 0.94
Clinically significant changes in burden and depression among dementia caregivers following nursing home admission. BMC Med (2010) 0.93
Risk factors and neuropsychological recovery in clients with alcohol use disorders who were exposed to different treatments. J Consult Clin Psychol (2004) 0.91
Psychopathology in children: improvement of quality of life without psychiatric symptom reduction? Eur Child Adolesc Psychiatry (2005) 0.90
The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population. J Am Acad Dermatol (2013) 0.86
Test of mindfulness and hope components in a psychological intervention for women with cancer recurrence. J Consult Clin Psychol (2014) 0.85
Is it possible to estimate the minimal clinically important treatment effect needed to change practice in preterm birth prevention? Results of an obstetrician survey used to support the design of a trial. BMC Med Res Methodol (2012) 0.84
The impact of changes in job strain and its components on the risk of depression. Am J Public Health (2011) 0.84
The clinical effectiveness of cognitive therapy for depression in an outpatient clinic. J Affect Disord (2010) 0.84
Collaborative assessment and management of suicidality in an inpatient setting: results of a pilot study. Psychotherapy (Chic) (2012) 0.84
Group CBT versus MBSR for social anxiety disorder: A randomized controlled trial. J Consult Clin Psychol (2016) 0.84
Changes in Positive Self-Views Mediate the Effect of Cognitive-Behavioral Therapy for Social Anxiety Disorder. Clin Psychol Sci (2013) 0.83
New Developments in the Psychological Management of Chronic Pain. Can J Psychiatry (2015) 0.82
An independent randomized clinical trial of multisystemic therapy with non-court-referred adolescents with serious conduct problems. J Consult Clin Psychol (2013) 0.82
Measuring clinically significant outcomes - LDQ, CORE-10 and SSQ as dimension measures of addiction. Psychiatr Bull (2014) (2014) 0.81
The severely impaired do profit most: short-term and long-term predictors of therapeutic change for a parent management training under routine care conditions for children with externalizing problem behavior. Eur Child Adolesc Psychiatry (2009) 0.80
Cognitive-behavioural suicide prevention for male prisoners: a pilot randomized controlled trial. Psychol Med (2015) 0.80
Internet-based, culturally sensitive, problem-solving therapy for Turkish migrants with depression: randomized controlled trial. J Med Internet Res (2013) 0.80
Validation of the Rasch-based Depression Screening in a large scale German general population sample. Health Qual Life Outcomes (2010) 0.80
Psychometric properties of the Positive Mental Health Scale (PMH-scale). BMC Psychol (2016) 0.79
Parent-child interaction therapy for preschool children with disruptive behaviour problems in the Netherlands. Child Adolesc Psychiatry Ment Health (2012) 0.79
Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future. Am J Drug Alcohol Abuse (2011) 0.79
Cognitive behavior therapy in the treatment of panic disorder. Indian J Psychiatry (2009) 0.78
Caloric vestibular stimulation in aphasic syndrome. Front Integr Neurosci (2013) 0.78
Effectiveness of dialectic behavioral therapy in routine outpatient care: the Berlin Borderline Study. Borderline Personal Disord Emot Dysregul (2014) 0.78
The Effectiveness of Parent Management Training-Oregon Model in Clinically Referred Children with Externalizing Behavior Problems in The Netherlands. Child Psychiatry Hum Dev (2017) 0.78
Psychosocial telephone intervention for dementia caregivers: A randomized, controlled trial. Alzheimers Dement (2014) 0.78
Clinical effectiveness of a residential pain management programme - comparing a large recent sample with previously published outcome data. Br J Pain (2015) 0.77
Feasibility study of an interactive multimedia electronic problem solving treatment program for depression: a preliminary uncontrolled trial. Behav Ther (2014) 0.76
Acceptance and Commitment Therapy for chronic pain: A diary study of treatment process in relation to reliable change in disability. J Contextual Behav Sci (2014) 0.76
Brief strategic therapy for obsessive-compulsive disorder: a clinical and research protocol of a one-group observational study. BMJ Open (2016) 0.76
A Case Study of Sexual Abuse and Psychological Correlates among an HIV-Serodiscordant Couple. Couple Family Psychol (2012) 0.76
Reducing therapist contact in cognitive behaviour therapy for panic disorder and agoraphobia in primary care: global measures of outcome in a randomised controlled trial. Br J Gen Pract (2000) 0.75
Transcranial magnetic stimulation for tinnitus: using the Tinnitus Functional Index to predict benefit in a randomized controlled trial. Trials (2017) 0.75
Effect of a classroom-based intervention on the social skills of pupils with intellectual disability in Southwest Nigeria. Child Adolesc Psychiatry Ment Health (2016) 0.75
Statistical versus clinical significance for infants with brain injury: reanalysis of outcome data from a randomized controlled study. Clin Nurs Res (2009) 0.75
Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up. Front Psychol (2017) 0.75
Research setting versus clinic setting: Which produces better outcomes in cognitive therapy for depression? Cognit Ther Res (2013) 0.75
Child Directed Interaction Training for young children in kinship care: A pilot study. Child Abuse Negl (2016) 0.75
What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J Eat Disord (2017) 0.75
Manualized Cognitive-Behavioral Treatment of Social Anxiety Disorder: A Case Study. Clin Case Stud (2012) 0.75
Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA. J Abnorm Child Psychol (2002) 0.75
Predictors of treatment attrition and treatment length in Parent-Child Interaction Therapy in Taiwanese families(.) Child Youth Serv Rev (2015) 0.75
Enhancement of executive functioning skills: an additional tier in the treatment of schizophrenia. Community Ment Health J (2002) 0.75
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A (1990) 5.31
Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door? N Engl J Med (1995) 4.77
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med (1991) 3.65
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J Biol Chem (1997) 3.42
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem (1990) 2.84
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A (1992) 2.51
Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol (1999) 2.40
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA (1999) 2.34
Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology (1999) 2.16
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res (1997) 2.02
Measurement of lipid peroxidation. Free Radic Res (1998) 1.91
Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest (1994) 1.89
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest (1992) 1.77
Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem (1994) 1.76
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy (2001) 1.62
Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A (1999) 1.57
Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci U S A (1985) 1.55
The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol (1996) 1.53
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins (1989) 1.49
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J Biol Chem (1999) 1.47
Are anaesthetists prone to suicide? A review of rates and risk factors. Anaesth Intensive Care (2003) 1.46
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Prevention of skin cancer in xeroderma pigmentosum: the physician as advocate. J Am Acad Dermatol (1993) 1.44
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
The effects of alcohol on the marital interactions of aggressive and nonaggressive husbands and their wives. J Abnorm Psychol (1998) 1.41
Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. J Biol Chem (1985) 1.40
Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Arch Dermatol (1991) 1.40
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1991) 1.39
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Placental isoprostane is significantly increased in preeclampsia. FASEB J (2000) 1.38
A physiologic concept of exercise-induced pulmonary hemorrhage in horses. J Am Vet Med Assoc (1992) 1.38
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun (2004) 1.33
Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol (1994) 1.33
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol (2013) 1.33
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem (1998) 1.33
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins (1992) 1.30
Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem (1982) 1.30
Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol (1992) 1.28
Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J Biol Chem (1999) 1.27
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest (1992) 1.26
Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann Neurol (1998) 1.23
Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim Biophys Acta (1994) 1.23
Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem (1994) 1.22
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol (2002) 1.20
Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. J Immunol (1979) 1.20
Clinical implications of prostaglandin and thromboxane A2 formation (2). N Engl J Med (1988) 1.19
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol (1993) 1.19
Increased CSF F2-isoprostane concentration in probable AD. Neurology (1999) 1.19
Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. Arch Biochem Biophys (1998) 1.16
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol (1992) 1.15
Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med (1999) 1.14
Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res (1990) 1.13
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. N Engl J Med (1981) 1.12
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am J Pathol (1999) 1.12
Increased lipid peroxidation in patients with rhabdomyolysis. Lancet (1999) 1.10
Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Adv Shock Res (1982) 1.10
Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med (1985) 1.09
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry (2000) 1.09
A nomenclature system for the isoprostanes. Prostaglandins (1997) 1.08
First trimester fetal nuchal translucency: problems with screening the general population. 2. Br J Obstet Gynaecol (1995) 1.08
Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv (1997) 1.07
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest (1994) 1.06
Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun (1993) 1.05
The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev (1999) 1.05
Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway. Biochemistry (1999) 1.04
Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Radic Biol Med (1997) 1.03
Preferential generation of prostaglandin D2 by rat and human mast cells. Kroc Found Ser (1981) 1.03
Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress. Free Radic Biol Med (1991) 1.03
Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. Biochemistry (1990) 1.03
Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care (2011) 1.03
Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol (1999) 1.02
Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins (1994) 1.02
Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum (1996) 1.01
Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology (1999) 1.00
Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1997) 1.00
Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem (1993) 0.98
Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview. Psychol Med (2007) 0.97
Collaborative research with a mutual help organization. Soc Policy (1985) 0.97
Calcium-dependent stimulation of thromboxane and prostaglandin biosynthesis by ionophores. Adv Prostaglandin Thromboxane Res (1978) 0.96
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96
Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. Prostaglandins (1985) 0.96
A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol (1998) 0.96
Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein. J Biol Chem (1999) 0.95
Identification of the major urinary metabolite of thromboxane B2 in the monkey. Prostaglandins (1977) 0.95
Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? J Pharmacol Exp Ther (1995) 0.95
Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res (1995) 0.94